Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04598386 · ClinicalTrials.gov registry record · NA
The Effect of AMP Human Sodium Bicarbonate Lotion on Hydration
A NA study, sponsored by University of Connecticut.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT04598386: Completed NA study, sponsored by University of Connecticut.
NCT04598386 is a NA study that has completed, run by University of Connecticut. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04598386, a NA study, has completed, sponsored by University of Connecticut.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this research study is to evaluate the effects of a topical sodium bicarbonate lotion on physiological and psychological responses associated with hydration status and fluid balance in humans during passive heat stress. Currently, the ingestion of sodium has been an effective measure for improvements in fluid regulation and hydration status in humans. However, the investigators do not know its regulatory relationship with measurements of fluid balance when supplemented through the skin.
Primary Outcome
Assessment of fluid retention via collection of urine volume
Interventions
- OTHER PR Lotion - AMP Human Performance
- OTHER Placebo Lotion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2020-12-09 |
| Est. Completion | 2021-04-09 |
| Phase | NA |
What the finished NCT04598386 record still lists
NCT04598386 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which PR Lotion - AMP Human Performance is the first listed.
NCT04598386 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04598386 about?
NCT04598386 is a clinical study titled "The Effect of AMP Human Sodium Bicarbonate Lotion on Hydration". The purpose of this research study is to evaluate the effects of a topical sodium bicarbonate lotion on physiological and psychological responses associated with hydration status and fluid balance in humans during passive heat stress. Currently, the ingestion of sodium has been an effective measure ...
What is the current status of trial NCT04598386?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2020-12-09. Estimated completion is 2021-04-09.
What interventions are being tested in trial NCT04598386?
The interventions under investigation include: PR Lotion - AMP Human Performance (OTHER), Placebo Lotion (OTHER).
Who is sponsoring clinical trial NCT04598386?
This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04598386's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI